Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
+64 3 470 9217
Email
simon.stebbings@otago.ac.nz
Position
Consultant Physician in Rheumatology
Department
Department of Medicine (Dunedin)
Qualifications
MB BS MMedSc FRCP(Lond) FRACP
Research summary
Rheumatology

Research

Professor Simon Stebbings' research has focused on ankylosing spondylitis and spondyloarthritis. Through national collaboration he established the multicentre Spondyloarthritis Genetics and the Environment Study (SAGE), which included a longitudinal study of outcomes in spondyloarthritis in New Zealand.

Through his membership of the International Genetics of Ankylosing Spondylitis study group he has contributed to the study of the genetic background to this common inflammatory arthritis.

Professor Stebbings is a member of the Assessment in Spondyloarthritis International Society (ASAS) and has contributed to the development of an ASAS Health Index. He is a member of the working group on management guidelines for axial spondyloarthritis for the Asia Pacific League Against Rheumatism.

Professor Stebbings has strong research links with the Department of Psychology and the School of Physiotherapy. Through collaborations with colleagues his research has investigated the importance of fatigue in rheumatic diseases, and the effectiveness of complementary therapies. He has been involved in research into the effects of smoking on arthritis and ways to encourage smoking cessation.

Publications

Bühler, M., Chapple, C., Stebbings, S., & Baxter, G. D. (2026). High dose soft orthosis for thumb carpometacarpal osteoarthritis in addition to best practice usual care: A feasibility randomised controlled trial. Hand Therapy. Advance online publication. doi: 10.1177/17589983261444954 Journal - Research Article

Stebbings, S., Dalbeth, N., Stamp, L., & Geddes, L. (2025). Bowel symptoms are common and persistent in axial spondylarthritis, impact quality of life, and correlate with both higher faecal calprotectin and disease activity scores. Annals of the Rheumatic Diseases, 84(Suppl. 1), (pp. 91). doi: 10.1016/j.ard.2025.05.123 Conference Contribution - Published proceedings: Abstract

Geddes, L., Wallace, M., Stamp, L., Harrison, A., White, D., Dalbeth, N., Ching, D., & Stebbings, S. M. (2025). In axial spondyloarthritis, bowel symptoms identified by questionnaire are prevalent, impact quality of life and correlate with faecal calprotectin and disease activity scores. Rheumatology, 64(Suppl. 3), P172. doi: 10.1093/rheumatology/keaf142.209 Conference Contribution - Published proceedings: Abstract

Chan, S. J., Stamp, L. K., Treharne, G. J., Cheung, J. M. Y., Dalbeth, N., Grainger, R., Stebbings, S., & Marra, C. A. (2025). Preferences for tapering biologic disease-modifying antirheumatic drugs among people with rheumatoid arthritis: A discrete choice experiment. Arthritis Care & Research, 77(3), 349-358. doi: 10.1002/acr.25437 Journal - Research Article

Kaur, G., Barclay, M., Mitchell, J., Jordan, S., & Stebbings, S. (2024). The prevalence and clinical features of leflunomide-associated peripheral neuropathy in patients with rheumatic disease in a New Zealand cohort. International Journal of Rheumatic Diseases, 27, e15317. doi: 10.1111/1756-185x.15317 Journal - Research Article

Back to top